Cell Therapeutics (CTIC)
Cell Therapeutics Cash Flow
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Cash Flow - Operations | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Income | -17.45M | -8.967M | -16.66M | -17.00M | -19.73M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation, Depletion, Amortization | 0.521M | 0.663M | 0.698M | 0.606M | 0.444M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Non-Cash Items | 1.90M | 2.727M | 0.844M | 1.092M | 0.641M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Non-Cash Items | 2.421M | 3.39M | 1.542M | 1.698M | 1.085M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Deferred Income Taxes | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Changes in Assets/Liabilities | -3.99M | 1.625M | -0.913M | 1.257M | -5.824M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Operating Activities | 0.023M | -1.716M | -0.09M | -0.023M | -0.129M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Cash from Operating Activities | -18.99M | -5.668M | -16.12M | -14.06M | -24.60M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash Flow - Investing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Capital Expenditures | -0.214M | -0.725M | -0.78M | -0.84M | -0.327M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Acquisitions, Divestitures | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Investments | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Investing Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Cash Flow - Financing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Cash from Investing Activities | -0.214M | -0.725M | -0.78M | -0.84M | -0.327M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Debt Issued | -10.91M | 0.00 | -10.25M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | ||
| Equity Issued | 18.74M | 27.98M | 14.78M | 47.09M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Dividends Paid | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Financing Activities | -0.087M | -0.059M | -5.872M | 5.717M | -0.21M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Cash from Financing Activities | -0.087M | 7.765M | 22.11M | 10.25M | 46.88M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Foreign Exchange Effects | -0.379M | 0.468M | 1.119M | -0.27M | -0.788M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Change in Cash & Cash Equivalents | -19.67M | 1.84M | 6.325M | -4.927M | 21.16M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at beginning of period | 47.05M | 22.65M | 47.05M | 45.21M | 38.89M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at end of period | 27.38M | 47.05M | 45.21M | 38.89M | 43.81M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
